Pluristem and U.S. Department of Defense Present Positive Data from Studies Testing PLX-R18 as a Prophylactic Treatment for Acute Radiation Syndrome

Ads

You May Also Like

Cidara Therapeutics to Present at Two Upcoming Conferences

SAN DIEGO, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology ...

Heat Biologics Appoints Jeff Hutchins, Ph.D., as Chief Scientific Officer

Industry veteran, Dr. Hutchins, to advance Heat’s platform technologies and pursue immunotherapy combinationsFormer CSO ...